Genemod
Private Company
Total funding raised: $1.5M
Overview
Genemod operates at the intersection of AI, lab informatics, and digital health, offering a cloud-based platform that consolidates core lab management functions. Its primary value proposition is replacing disparate tools like spreadsheets and legacy systems with an integrated solution that enhances data integrity, operational efficiency, and compliance. The company serves a diverse customer base, from academic startups to regulated industrial labs managing millions of records, and is positioned to capitalize on the growing digitization of life sciences R&D.
Technology Platform
A unified, AI-powered cloud platform combining Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN) capabilities for end-to-end management of experiments, samples, inventory, and lab operations.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Genemod competes in a crowded market including broad-purpose ELN leaders like Benchling, legacy LIMS providers (LabVantage, Thermo Fisher), inventory managers (Quartzy), and spreadsheet software. Its key differentiators are the unified LIMS/ELN approach, AI integration, and a focus on user experience for scalable, traceable operations.